Recent research focusing on Tirzepatide at a dosage of 40mg is shedding new light on its potential benefits. Initial findings suggest that this higher dosage may amplify the drug's ability to manage blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully evaluate t